These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 35879430)
1. Exploration of the amino acid metabolic signature in anthracycline-induced cardiotoxicity using an optimized targeted metabolomics approach based on UPLC-MS/MS. Li W; Li S; Cao Z; Sun Y; Qiu W; Jia M; Su M Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1209-1224. PubMed ID: 35879430 [TBL] [Abstract][Full Text] [Related]
2. Pretreatment of 3-MA prevents doxorubicin-induced cardiotoxicity through inhibition of autophagy initiation. Sun X; Meng H; Xiao J; Liu F; Du J; Zeng H Toxicology; 2023 May; 490():153512. PubMed ID: 37062353 [TBL] [Abstract][Full Text] [Related]
3. Plasma metabolic profiling analysis of cyclophosphamide-induced cardiotoxicity using metabolomics coupled with UPLC/Q-TOF-MS and ROC curve. Yin J; Xie J; Guo X; Ju L; Li Y; Zhang Y J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():428-435. PubMed ID: 27649503 [TBL] [Abstract][Full Text] [Related]
4. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis. Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577 [TBL] [Abstract][Full Text] [Related]
5. Network-driven targeted analysis reveals that Astragali Radix alleviates doxorubicin-induced cardiotoxicity by maintaining fatty acid homeostasis. Han Z; Guo L; Yu X; Guo H; Deng X; Yu J; Deng X; Xu F; Zhang Z; Huang Y J Ethnopharmacol; 2022 Apr; 287():114967. PubMed ID: 34995692 [TBL] [Abstract][Full Text] [Related]
6. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes. Menna P; Salvatorelli E; Minotti G Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277 [TBL] [Abstract][Full Text] [Related]
7. Investigation of the reverse effect of Danhong injection on doxorubicin-induced cardiotoxicity in H9c2 cells: Insight by LC-MS based non-targeted metabolomic analysis. Yi X; Zhu J; Zhang J; Gao Y; Chen Z; Lu S; Cai Z; Hong Y; Wu Y J Pharm Biomed Anal; 2018 Apr; 152():264-270. PubMed ID: 29438868 [TBL] [Abstract][Full Text] [Related]
8. Ultra-Performance Liquid Chromatography-Q-Exactive Orbitrap-Mass Spectrometry Analysis for Metabolic Communication between Heart and Kidney in Adriamycin-Induced Nephropathy Rats. Wang C; Liang J; Yang W; Wang S; Yu J; Jia P; Du Y; Wang M; Li Y; Zheng X Kidney Blood Press Res; 2022; 47(1):31-42. PubMed ID: 34662875 [TBL] [Abstract][Full Text] [Related]
9. Characterizing metabolites and potential metabolic pathways changes to understanding the mechanism of medicinal plant Phellodendri Amurensis cortex against doxorubicin-induced nephritis rats using UPLC-Q/TOF-MS metabolomics. Zhang H; Zhang S; Wang W; Wang Q; Kuang H; Wang Q J Pharm Biomed Anal; 2020 Sep; 188():113336. PubMed ID: 32653762 [TBL] [Abstract][Full Text] [Related]
10. Metabonomics study on orthotopic transplantion mice model of colon cancer treated with Astragalus membranaceus-Curcuma wenyujin in different proportions via UPLC-Q-TOF/MS. Sun R; Gu J; Chang X; Liu F; Liang Y; Yang X; Liang L; Tang D J Pharm Biomed Anal; 2021 Jan; 193():113708. PubMed ID: 33129117 [TBL] [Abstract][Full Text] [Related]
11. HMGB1 contributes to adriamycin-induced cardiotoxicity via up-regulating autophagy. Luo P; Zhu Y; Chen M; Yan H; Yang B; Yang X; He Q Toxicol Lett; 2018 Aug; 292():115-122. PubMed ID: 29715512 [TBL] [Abstract][Full Text] [Related]
12. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS. Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807 [TBL] [Abstract][Full Text] [Related]
13. Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabolomic analysis of Veratrum nigrum-induced cardiotoxicity. Wei Z; Dong X; Zhang H; Gao S; Shi W; Yang F; Dong X Biomed Chromatogr; 2017 Dec; 31(12):. PubMed ID: 28544073 [TBL] [Abstract][Full Text] [Related]
14. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry]. Guo M; Zhang J Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158 [TBL] [Abstract][Full Text] [Related]
15. Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography-mass spectrometry. Zhang R; Zhuang X; Zong L; Liu S; Liu Z; Song F Anal Bioanal Chem; 2016 Aug; 408(21):5843-5854. PubMed ID: 27379392 [TBL] [Abstract][Full Text] [Related]
16. Deep learning-assisted high-content screening identifies isoliquiritigenin as an inhibitor of DNA double-strand breaks for preventing doxorubicin-induced cardiotoxicity. Chen X; Liu C; Zhao H; Zhong Y; Xu Y; Wang Y Biol Direct; 2023 Oct; 18(1):63. PubMed ID: 37807075 [TBL] [Abstract][Full Text] [Related]
17. Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival. Vantaku V; Donepudi SR; Piyarathna DWB; Amara CS; Ambati CR; Tang W; Putluri V; Chandrashekar DS; Varambally S; Terris MK; Davies K; Ambs S; Bollag R; Apolo AB; Sreekumar A; Putluri N Cancer; 2019 Mar; 125(6):921-932. PubMed ID: 30602056 [TBL] [Abstract][Full Text] [Related]
18. Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation. Jirkovský E; Jirkovská A; Bavlovič-Piskáčková H; Skalická V; Pokorná Z; Karabanovich G; Kollárová-Brázdová P; Kubeš J; Lenčová-Popelová O; Mazurová Y; Adamcová M; Lyon AR; Roh J; Šimůnek T; Štěrbová-Kovaříková P; Štěrba M Circ Heart Fail; 2021 Nov; 14(11):e008209. PubMed ID: 34551586 [TBL] [Abstract][Full Text] [Related]
19. Identifying Metabolic Perturbations and Toxic Effects of Zhang P; Wang S; He Y; Xu Y; Shi D; Yang F; Yu W; Zhu W; He L Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683916 [TBL] [Abstract][Full Text] [Related]
20. Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression. Lu Y; Liu W; Lv T; Wang Y; Liu T; Chen Y; Jin Y; Huang J; Zheng L; Huang Y; He Y; Li Y Pharm Biol; 2022 Dec; 60(1):1616-1624. PubMed ID: 35980105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]